BRAF and melanoma: Future research should continue to focus on optimizing existing therapies, identifying and validating new therapeutic targets, and developing more precise and personalized approaches to overcome the intrinsic and acquired resistance mechanisms characteristic of BRAF-mutant melanoma [87,88].